{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T18:34:11Z","timestamp":1774895651976,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T00:00:00Z","timestamp":1493856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11684-017-0518-7","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T01:16:29Z","timestamp":1493860589000},"page":"214-222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer"],"prefix":"10.1007","volume":"11","author":[{"given":"Bo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongbin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ensong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lili","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanying","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Degui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danhui","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,4]]},"reference":[{"issue":"1","key":"518_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63(1): 11\u201330","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"518_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","volume":"26","author":"CN Landen","year":"2008","unstructured":"Landen CN, Birrer MJ, Sood AK. Early events in the pathogenesis of epithelial ovarian cancer. J Clin Oncol 2008; 26(6): 995\u20131005","journal-title":"J Clin Oncol"},{"issue":"1","key":"518_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","volume":"4","author":"KR Cho","year":"2009","unstructured":"Cho KR, Shih Ie M. Ovarian cancer. Annu Rev Pathol 2009; 4(1): 287\u2013313","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"518_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2): 281\u2013297","journal-title":"Cell"},{"issue":"25","key":"518_CR5","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1056\/NEJMe0808667","volume":"359","author":"FJ Slack","year":"2008","unstructured":"Slack FJ, Weidhaas JB. MicroRNA in cancer prognosis. N Engl J Med 2008; 359(25): 2720\u20132722","journal-title":"N Engl J Med"},{"issue":"1","key":"518_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","volume":"122","author":"CM Croce","year":"2005","unstructured":"Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005; 122(1): 6\u20137","journal-title":"Cell"},{"issue":"5654","key":"518_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1126\/science.1091903","volume":"303","author":"CZ Chen","year":"2004","unstructured":"Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303(5654): 83\u201386","journal-title":"Science"},{"issue":"3","key":"518_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ncb2024","volume":"12","author":"L Ma","year":"2010","unstructured":"Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya- Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F, Speleman F, Vandesompele J, Weinberg RA. miR-9, a MYC\/ MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12(3): 247\u2013256","journal-title":"Nat Cell Biol"},{"issue":"22","key":"518_CR9","doi-asserted-by":"crossref","first-page":"11669","DOI":"10.18632\/oncotarget.2581","volume":"5","author":"Y Song","year":"2014","unstructured":"Song Y, Li J, Zhu Y, Dai Y, Zeng T, Liu L, Li J, Wang H, Qin Y, Zeng M, Guan XY, Li Y. MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma. Oncotarget 2014; 5(22): 11669\u201311680","journal-title":"Oncotarget"},{"issue":"5","key":"518_CR10","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.molonc.2013.04.007","volume":"7","author":"Z Sun","year":"2013","unstructured":"Sun Z, Han Q, Zhou N,Wang S, Lu S, Bai C, Zhao RC. MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol 2013; 7(5): 884\u2013894","journal-title":"Mol Oncol"},{"issue":"2","key":"518_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s12032-011-9975-z","volume":"29","author":"L Zhu","year":"2012","unstructured":"Zhu L, Chen H, Zhou D, Li D, Bai R, Zheng S, Ge W. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol 2012; 29(2): 1037\u20131043","journal-title":"Med Oncol"},{"issue":"5","key":"518_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/CMR.0b013e328363e485","volume":"23","author":"R Shiiyama","year":"2013","unstructured":"Shiiyama R, Fukushima S, Jinnin M, Yamashita J, Miyashita A, Nakahara S, Kogi A, Aoi J, Masuguchi S, Inoue Y, Ihn H. Sensitive detection of melanoma metastasis using circulating microRNA expression profiles. Melanoma Res 2013; 23(5): 366\u2013372","journal-title":"Melanoma Res"},{"issue":"18","key":"518_CR13","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","volume":"67","author":"MV Iorio","year":"2007","unstructured":"Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM. MicroRNA signatures in human ovarian cancer. Cancer Res 2007; 67(18): 8699\u20138707","journal-title":"Cancer Res"},{"issue":"1","key":"518_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-4598-7-35","volume":"7","author":"A Laios","year":"2008","unstructured":"Laios A, O\u2019Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D\u2019Arcy T, McGuinness E, Sheils O, Sheppard B, O\u2019 Leary J. Potential role of miR-9 and miR-223 in recurrent ovarian cancer. Mol Cancer 2008; 7(1): 35","journal-title":"Mol Cancer"},{"issue":"22","key":"518_CR15","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1093\/jnci\/djt302","volume":"105","author":"C Sun","year":"2013","unstructured":"Sun C, Li N, Yang Z, Zhou B, He Y, Weng D, Fang Y, Wu P, Chen P, Yang X, Ma D, Zhou J, Chen G. miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition. J Natl Cancer Inst 2013; 105(22): 1750\u20131758","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"518_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2(6): 442\u2013454","journal-title":"Nat Rev Cancer"},{"key":"518_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1201\/EBK1439814888-c2","volume":"2","author":"Y Dai","year":"2010","unstructured":"Dai Y, Zhou X. Computational methods for the identification of microRNA targets. Open Access Bioinformatics 2010; 2:29\u201339","journal-title":"Open Access Bioinformatics"},{"issue":"5","key":"518_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jbi.2011.05.002","volume":"44","author":"H Dweep","year":"2011","unstructured":"Dweep H, Sticht C, Pandey P, Gretz N. miRWalk\u2013database: prediction of possible miRNA binding sites by \u201cwalking\u201d the genes of three genomes. J Biomed Inform 2011; 44(5): 839\u2013847","journal-title":"J Biomed Inform"},{"issue":"2","key":"518_CR19","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"CC Liang","year":"2007","unstructured":"Liang CC, Park AY, Guan JL. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2007; 2(2): 329\u2013333","journal-title":"Nat Protoc"},{"issue":"2","key":"518_CR20","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ymeth.2005.08.001","volume":"37","author":"A Valster","year":"2005","unstructured":"Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods 2005; 37(2): 208\u2013215","journal-title":"Methods"},{"issue":"2","key":"518_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.canlet.2008.08.027","volume":"273","author":"D Weng","year":"2009","unstructured":"Weng D, Song X, Xing H, Ma X, Xia X, Weng Y, Zhou J, Xu G, Meng L, Zhu T, Wang S, Ma D. Implication of the Akt2\/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells. Cancer Lett 2009; 273(2): 257\u2013265","journal-title":"Cancer Lett"},{"issue":"5","key":"518_CR22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelialmesenchymal transitions in development and disease. Cell 2009; 139(5): 871\u2013890","journal-title":"Cell"},{"issue":"1","key":"518_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","volume":"291","author":"D Vergara","year":"2010","unstructured":"Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I, Salzet M. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett 2010; 291(1): 59\u201366","journal-title":"Cancer Lett"},{"issue":"19","key":"518_CR24","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.1158\/0008-5472.CAN-09-2111","volume":"69","author":"DR Hurst","year":"2009","unstructured":"Hurst DR, Edmonds MD, Welch DR. MetastamiR: the field of metastasis-regulatory microRNA is spreading. Cancer Res 2009; 69(19): 7495\u20137498","journal-title":"Cancer Res"},{"issue":"9","key":"518_CR25","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1002\/dvdy.20847","volume":"235","author":"M Deo","year":"2006","unstructured":"Deo M, Yu JY, Chung KH, Tippens M, Turner DL. Detection of mammalian microRNA expression by in situ hybridization with RNA oligonucleotides. Dev Dyn 2006; 235(9): 2538\u20132548","journal-title":"Dev Dyn"},{"issue":"3","key":"518_CR26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1750-3639.2008.00184.x","volume":"19","author":"D Nass","year":"2009","unstructured":"Nass D, Rosenwald S, Meiri E, Gilad S, Tabibian-Keissar H, Schlosberg A, Kuker H, Sion-Vardy N, Tobar A, Kharenko O, Sitbon E, Lithwick Yanai G, Elyakim E, Cholakh H, Gibori H, Spector Y, Bentwich Z, Barshack I, Rosenfeld N. miR-92b and miR-9\/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol 2009; 19(3): 375\u2013383","journal-title":"Brain Pathol"},{"issue":"2","key":"518_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3892\/or.2012.1846","volume":"28","author":"X Luo","year":"2012","unstructured":"Luo X, Fan S, Huang W, Zhai S, Ma Z, Li P, Sun SY, Wang X. Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma. Oncol Rep 2012; 28(2): 659\u2013667","journal-title":"Oncol Rep"},{"issue":"23","key":"518_CR28","doi-asserted-by":"publisher","first-page":"6416","DOI":"10.1158\/1078-0432.CCR-12-0832","volume":"18","author":"MH Lu","year":"2012","unstructured":"Lu MH, Huang CC, Pan MR, Chen HH, Hung WC. Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9. Clin Cancer Res 2012; 18(23): 6416\u20136425","journal-title":"Clin Cancer Res"},{"issue":"1","key":"518_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10549-014-3069-5","volume":"147","author":"JM Gwak","year":"2014","unstructured":"Gwak JM, Kim HJ, Kim EJ, Chung YR, Yun S, Seo AN, Lee HJ, Park SY. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat 2014; 147(1): 39\u201349","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"518_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/onc.2012.20","volume":"32","author":"SM Wilting","year":"2013","unstructured":"Wilting SM, Snijders PJ, Verlaat W, Jaspers A, van de Wiel MA, van Wieringen WN, Meijer GA, Kenter GG, Yi Y, le Sage C, Agami R, Meijer CJ, Steenbergen RD. Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis. Oncogene 2013; 32(1): 106\u2013116","journal-title":"Oncogene"},{"issue":"1","key":"518_CR31","doi-asserted-by":"publisher","first-page":"e55719","DOI":"10.1371\/journal.pone.0055719","volume":"8","author":"L Zheng","year":"2013","unstructured":"Zheng L, Qi T, Yang D, Qi M, Li D, Xiang X, Huang K, Tong Q. MicroRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One 2013; 8(1): e55719","journal-title":"PLoS One"},{"issue":"7","key":"518_CR32","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.4161\/cbt.7.7.6208","volume":"7","author":"N Omura","year":"2008","unstructured":"Omura N, Li CP, Li A, Hong SM, Walter K, Jimeno A, Hidalgo M, Goggins M. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma. Cancer Biol Ther 2008; 7(7): 1146\u20131156","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"518_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.2251","volume":"214","author":"U Lehmann","year":"2008","unstructured":"Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, Kreipe H. Epigenetic inactivation of microRNA gene hsamir- 9\u20131 in human breast cancer. J Pathol 2008; 214(1): 17\u201324","journal-title":"J Pathol"},{"issue":"6","key":"518_CR34","first-page":"1759","volume":"27","author":"T Inoue","year":"2012","unstructured":"Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R. Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 2012; 27(6): 1759\u20131764","journal-title":"Oncol Rep"},{"issue":"3","key":"518_CR35","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1039\/c3mb70479c","volume":"10","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, Luo X, Kan T, Zhang Y, Yu W, Wei Y, Shen N, Yi B, Jiang X. TGF-\u00df upregulates miR-182 expression to promote gallbladder cancer metastasis by targeting CADM1. Mol Biosyst 2014; 10(3): 679\u2013685","journal-title":"Mol Biosyst"},{"key":"518_CR36","doi-asserted-by":"publisher","first-page":"13884","DOI":"10.1038\/ncomms13884","volume":"7","author":"J Yu","year":"2016","unstructured":"Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, Segura MF, Zhang X, Hu G. MicroRNA-182 targets SMAD7 to potentiate TGF\u00df-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun 2016; 7: 13884","journal-title":"Nat Commun"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11684-017-0518-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-017-0518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-017-0518-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T22:06:05Z","timestamp":1602021965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11684-017-0518-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s11684-017-0518-7","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,4]]}}}